Mycobacterial lung disease in cystic fibrosis: A prospective study

被引:92
作者
Fauroux, B
Delaisi, B
Clement, A
Saizou, C
Moissenet, D
TruffotPernot, C
Tournier, G
Thien, HV
机构
[1] HOP ENFANTS ARMAND TROUSSSEAU, DEPT MICROBIOL, PARIS, FRANCE
[2] HOP LA PITIE SALPETRIERE, DEPT MICROBIOL, PARIS, FRANCE
关键词
cystic fibrosis; mycobacteria; mycobacterial lung disease;
D O I
10.1097/00006454-199704000-00004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Patients with cystic fibrosis (CF) may be predisposed to airway infections with unusual organisms, such as mycobacteria. The aim of the study was to determine the incidence and clinical picture of mycobacterial infection in CF children. Methods. At least 2 acid-fast bacillus (AFB) smears and mycobacterial cultures were performed on a prospective basis on 682 sputum specimens from 106 patients during a 1-year period. Results. Thirty-three percent of the cultures were contaminated with other bacteria. Seven children had at least one sputum culture positive for one mycobacterium. Five children had only one positive AFB culture. Their clinical status and lung function remained stable during followup. Two teenagers with severe lung disease had several positive AFB smears and cultures for Mycobacterium chelonae and Mycobacterium abscessus. The isolation of M. chelonae and M. abscessus was associated with a clinical and functional decline. Clarithromycin treatment resulted in temporary improvement with the disappearance of the mycobacteria after 6 months of treatment. This prospective study shows an incidence of 2.3% for positive cultures. The prevalence was 6.6% for mycobacterial colonization but only 1.9% for mycobacterial lung disease in our pediatric population. Conclusions. We recommend performing AFB smears and cultures in CF children with severe lung disease and/or during a lung exacerbation. In these patients persistence of M chelonae or M. abscessus in sputum should lead to consideration of treatment with clarithromycin.
引用
收藏
页码:354 / 358
页数:5
相关论文
共 22 条
  • [1] NONTUBERCULOUS MYCOBACTERIAL DISEASE IN ADULT CYSTIC-FIBROSIS PATIENTS
    AITKEN, ML
    BURKE, W
    MCDONALD, G
    WALLIS, C
    RAMSEY, B
    NOLAN, C
    [J]. CHEST, 1993, 103 (04) : 1096 - 1099
  • [2] [Anonymous], 1979, AM REV RESPIR DIS, V119, P831
  • [3] ISOLATION OF RAPIDLY GROWING MYCOBACTERIA IN PATIENTS WITH CYSTIC-FIBROSIS
    BOXERBAUM, B
    [J]. JOURNAL OF PEDIATRICS, 1980, 96 (04) : 689 - 691
  • [4] ACTIVITIES OF 4 MACROLIDES, INCLUDING CLARITHROMYCIN, AGAINST MYCOBACTERIUM-FORTUITUM, MYCOBACTERIUM-CHELONAE, AND M-CHELONAE-LIKE ORGANISMS
    BROWN, BA
    WALLACE, RJ
    ONYI, GO
    DEROSAS, V
    WALLACE, RJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) : 180 - 184
  • [5] *COM ANT SOC FRANC, 1995, PATHOL BIOL, V43, P1
  • [6] CLARITHROMYCIN IN THE TREATMENT OF MYCOBACTERIUM-AVIUM LUNG INFECTIONS IN PATIENTS WITHOUT AIDS
    DAUTZENBERG, B
    PIPERNO, D
    DIOT, P
    TRUFFOTPERNOT, C
    CHAUVIN, JP
    [J]. CHEST, 1995, 107 (04) : 1035 - 1040
  • [7] LONG-TERM RESULTS OF MEDICAL-TREATMENT IN MYCOBACTERIUM INTRACELLULARE INFECTION
    DUTT, AK
    STEAD, WW
    [J]. AMERICAN JOURNAL OF MEDICINE, 1979, 67 (03) : 449 - 453
  • [8] EFTHIMIOU J, 1984, BRIT J DIS CHEST, V78, P299, DOI 10.1016/0007-0971(84)90146-3
  • [9] GAULTIER C, 1974, SEM HOP PARIS, V50, P1045
  • [10] GEVAUDAN MJ, 1994, PATHOL BIOL, V42, P412